SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244471
Filing Date
2018-08-09
Accepted
2018-08-09 16:47:17
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d474895d10q.htm 10-Q 580919
2 EX-31.1 d474895dex311.htm EX-31.1 6284
3 EX-31.2 d474895dex312.htm EX-31.2 6266
4 EX-32.1 d474895dex321.htm EX-32.1 5623
  Complete submission text file 0001193125-18-244471.txt   3042667

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20180630.xml EX-101.INS 496508
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20180630.xsd EX-101.SCH 38492
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20180630_cal.xml EX-101.CAL 46283
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20180630_def.xml EX-101.DEF 114161
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20180630_lab.xml EX-101.LAB 304778
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20180630_pre.xml EX-101.PRE 216050
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 181005986
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences